Neuroimage-guided Dual-target Continuous Theta Burst Stimulation for Generalized Anxiety Disorder
Key facts
- Who runs it
- Anhui Medical University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 60 people, planned
- Started
- 1 Nov 2024
- Ended
- 1 Nov 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Continuous theta-burst stimulation
- sham continuous theta-burst stimulation
- Record updated
- 22 August 2025
Who can take part
- Age
- 18 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (10)Hide the full registry criteria
Who can take part
- the patients were diagnosed by more than 2 psychiatrists and met the diagnostic criteria of DSM-5 for anxiety
- HAMA score ≥ 14 (HAMD score < 17)
- Age range: 18-60 years
- Right-handed
- Able to cooperate with the collection of general demographic information and neuropsychological testing
- Patients are either medication-free or maintain a consistent medication regimen during cTBS treatment.-
Who cannot take part
- History of alcohol or drug dependence
- Diagnosis of other neuropsychiatric disorders, such as epilepsy, autism, obsessive-compulsive disorder, or autoimmune encephalitis
- Presence of organic brain lesions detected on MRI
- Contraindications to MRI scanning.-
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of this clinical trial was to determine whether image-guided dual-target cTBS is effective for anxiety disorders. The main questions it aims to answer are:
Read full original descriptionShow less
1. Does dual-target cTBS improve patients' anxiety symptoms? 2. Does dual-target cTBS improve patients' somatization symptoms? 3. Researchers will compare cTBS real and sham stimulation to determine whether cTBS is effective in treating anxiety disorders.
Participants will:
1. Received either cTBS treatment or sham stimulation for 7 consecutive days 2. Psychological assessment and MRI scan were performed before treatment, within 2 days, 2 weeks and 1 month after treatment 3. Adverse reactions during the experiment were recorded
The 2 groups in the trial
- active cTBS groupExisting treatment, for comparison
Dual-target active cTBS will be performed over 7 consecutive days
Treatment: Continuous theta-burst stimulation
- sham cTBS groupSham treatment, for comparison
Sham stimulation of dual-target cTBS was performed for 7 consecutive days using a sham coil
Treatment: sham continuous theta-burst stimulation
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 22 August 2025